chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Infectious mononucleosis, Pain in extremity
Clinical narrative: Arm hurt; Slight headache; Felt tired; Diagnosed with Mononucleosis; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurt), INFECTIOUS MONONUCLEOSIS (Diagnosed with Mononucleosis), HEADACHE (Slight headache) and FATIGUE (Felt tired) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 030L20A) for COVID-19 vaccination.     The patient's past medical history included AFib.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Aug-2021, the patient experienced INFECTIOUS MONONUCLEOSIS (Diagnosed with Mononucleosis). On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm hurt), HEADACHE (Slight headache) and FATIGUE (Felt tired). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm hurt), HEADACHE (Slight headache) and FATIGUE (Felt tired) had resolved and INFECTIOUS MONONUCLEOSIS (Diagnosed with Mononucleosis) outcome was unknown.            No concominant medication is provided.   This case was linked to MOD-2021-290723 (Patient Link).
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills
Clinical narrative: I had chills for about 20 minutes.; This spontaneous case was reported by an other health care professional and describes the occurrence of CHILLS (I had chills for about 20 minutes.) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 026L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Jan-2021, the patient experienced CHILLS (I had chills for about 20 minutes.). At the time of the report, CHILLS (I had chills for about 20 minutes.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 97 (Low) 97'F.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medication reported.  No treatment medication reported.  The patient received the 1st dose of the Moderna Covid-19 vaccine. Reported having chills for about 20 minutes.  She didn't take her temperature. Her normal temperature was 97degree F. She was always low.  03Feb2021: Received the 2nd dose of the Moderna Covid-19 vaccine. No side effects to report.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Limb discomfort, Malaise
Clinical narrative: felt a tiny bit under the weather/was feeling under the weather on and off; headache/had a headache which he describes as very slight, nothing crazy; with the exact same thing happening to his big toe on his right foot; felt like gout on the back or heel of his left foot; The joint was sore and not feeling right; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (felt like gout on the back or heel of his left foot), LIMB DISCOMFORT (with the exact same thing happening to his big toe on his right foot), MALAISE (felt a tiny bit under the weather/was feeling under the weather on and off), HEADACHE (headache/had a headache which he describes as very slight, nothing crazy) and ARTHRALGIA (The joint was sore and not feeling right) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Aug-2021 at 5:03 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Aug-2021, the patient experienced LIMB DISCOMFORT (felt like gout on the back or heel of his left foot) and ARTHRALGIA (The joint was sore and not feeling right). On 18-Aug-2021, the patient experienced LIMB DISCOMFORT (with the exact same thing happening to his big toe on his right foot). On an unknown date, the patient experienced MALAISE (felt a tiny bit under the weather/was feeling under the weather on and off) and HEADACHE (headache/had a headache which he describes as very slight, nothing crazy). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, LIMB DISCOMFORT (felt like gout on the back or heel of his left foot) and ARTHRALGIA (The joint was sore and not feeling right) had resolved and LIMB DISCOMFORT (with the exact same thing happening to his big toe on his right foot), MALAISE (felt a tiny bit under the weather/was feeling under the weather on and off) and HEADACHE (headache/had a headache which he describes as very slight, nothing crazy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs were reported
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Pyrexia, SARS-CoV-2 antibody test
Clinical narrative: Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 001A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Body temperature increased: high (High) 103 degrees Fahrenheit. In 2021, SARS-CoV-2 antibody test: positive (Positive) Positive.          No concomitant medications were provided.  No treatment medications were provided.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Feeling abnormal, Pain in extremity
Clinical narrative: Dizziness; Pain in her arm; Felt weak/Didn't feel energetic; Didn't feel good; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), PAIN IN EXTREMITY (Pain in her arm), ASTHENIA (Felt weak/Didn't feel energetic) and FEELING ABNORMAL (Didn't feel good) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included PARACETAMOL (TYLENOL) and IBUPROFEN for an unknown indication.    In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness), PAIN IN EXTREMITY (Pain in her arm), ASTHENIA (Felt weak/Didn't feel energetic) and FEELING ABNORMAL (Didn't feel good). At the time of the report, DIZZINESS (Dizziness) and PAIN IN EXTREMITY (Pain in her arm) had resolved and ASTHENIA (Felt weak/Didn't feel energetic) and FEELING ABNORMAL (Didn't feel good) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The treatment information was not provided.    This case was linked to MOD-2021-290867 (Patient Link).
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Erythema, Influenza like illness, Malaise
Clinical narrative: Just didn't feel good; Arm was swollen to the elbow; Arm was red; Redness/swelling/lumpiness began to wrap around her arm to her armpit; Lumps the size of quarters in a 4 x4 inch patch, 3 inches below injection site; Light itching all over her body; Achy Muscle and joints; Nausea; Achy Muscle and joints; Arm hurt; Migraine; Vertigo; Dizziness; Flu like; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurt), MIGRAINE (Migraine), VERTIGO (Vertigo), DIZZINESS (Dizziness) and INFLUENZA LIKE ILLNESS (Flu like) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm hurt), MIGRAINE (Migraine), VERTIGO (Vertigo), DIZZINESS (Dizziness), INFLUENZA LIKE ILLNESS (Flu like), ARTHRALGIA (Achy Muscle and joints), NAUSEA (Nausea) and MYALGIA (Achy Muscle and joints). On 19-Feb-2021, the patient experienced VACCINATION SITE MASS (Lumps the size of quarters in a 4 x4 inch patch, 3 inches below injection site) and PRURITUS (Light itching all over her body). On 24-Feb-2021, the patient experienced PERIPHERAL SWELLING (Arm was swollen to the elbow), ERYTHEMA (Arm was red) and SKIN MASS (Redness/swelling/lumpiness began to wrap around her arm to her armpit). In May 2021, the patient experienced MALAISE (Just didn't feel good). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. On 24-Feb-2021, PAIN IN EXTREMITY (Arm hurt), MIGRAINE (Migraine), VERTIGO (Vertigo), DIZZINESS (Dizziness), INFLUENZA LIKE ILLNESS (Flu like), ARTHRALGIA (Achy Muscle and joints), NAUSEA (Nausea) and MYALGIA (Achy Muscle and joints) had resolved. At the time of the report, VACCINATION SITE MASS (Lumps the size of quarters in a 4 x4 inch patch, 3 inches below injection site), PRURITUS (Light itching all over her body), MALAISE (Just didn't feel good), PERIPHERAL SWELLING (Arm was swollen to the elbow), ERYTHEMA (Arm was red) and SKIN MASS (Redness/swelling/lumpiness began to wrap around her arm to her armpit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.     This case was linked to MOD-2021-291127, MOD-2021-291781.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Myalgia, Nausea, Pain in extremity, Peripheral swelling
Clinical narrative: Just didn't feel good; Arm was swollen to the elbow; Arm was red; Redness/swelling/lumpiness began to wrap around her arm to her armpit; Lumps the size of quarters in a 4 x4 inch patch, 3 inches below injection site; Light itching all over her body; Achy Muscle and joints; Nausea; Achy Muscle and joints; Arm hurt; Migraine; Vertigo; Dizziness; Flu like; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurt), MIGRAINE (Migraine), VERTIGO (Vertigo), DIZZINESS (Dizziness) and INFLUENZA LIKE ILLNESS (Flu like) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm hurt), MIGRAINE (Migraine), VERTIGO (Vertigo), DIZZINESS (Dizziness), INFLUENZA LIKE ILLNESS (Flu like), ARTHRALGIA (Achy Muscle and joints), NAUSEA (Nausea) and MYALGIA (Achy Muscle and joints). On 19-Feb-2021, the patient experienced VACCINATION SITE MASS (Lumps the size of quarters in a 4 x4 inch patch, 3 inches below injection site) and PRURITUS (Light itching all over her body). On 24-Feb-2021, the patient experienced PERIPHERAL SWELLING (Arm was swollen to the elbow), ERYTHEMA (Arm was red) and SKIN MASS (Redness/swelling/lumpiness began to wrap around her arm to her armpit). In May 2021, the patient experienced MALAISE (Just didn't feel good). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. On 24-Feb-2021, PAIN IN EXTREMITY (Arm hurt), MIGRAINE (Migraine), VERTIGO (Vertigo), DIZZINESS (Dizziness), INFLUENZA LIKE ILLNESS (Flu like), ARTHRALGIA (Achy Muscle and joints), NAUSEA (Nausea) and MYALGIA (Achy Muscle and joints) had resolved. At the time of the report, VACCINATION SITE MASS (Lumps the size of quarters in a 4 x4 inch patch, 3 inches below injection site), PRURITUS (Light itching all over her body), MALAISE (Just didn't feel good), PERIPHERAL SWELLING (Arm was swollen to the elbow), ERYTHEMA (Arm was red) and SKIN MASS (Redness/swelling/lumpiness began to wrap around her arm to her armpit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.     This case was linked to MOD-2021-291127, MOD-2021-291781.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Skin mass, Vaccination site mass, Vertigo
Clinical narrative: Just didn't feel good; Arm was swollen to the elbow; Arm was red; Redness/swelling/lumpiness began to wrap around her arm to her armpit; Lumps the size of quarters in a 4 x4 inch patch, 3 inches below injection site; Light itching all over her body; Achy Muscle and joints; Nausea; Achy Muscle and joints; Arm hurt; Migraine; Vertigo; Dizziness; Flu like; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurt), MIGRAINE (Migraine), VERTIGO (Vertigo), DIZZINESS (Dizziness) and INFLUENZA LIKE ILLNESS (Flu like) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm hurt), MIGRAINE (Migraine), VERTIGO (Vertigo), DIZZINESS (Dizziness), INFLUENZA LIKE ILLNESS (Flu like), ARTHRALGIA (Achy Muscle and joints), NAUSEA (Nausea) and MYALGIA (Achy Muscle and joints). On 19-Feb-2021, the patient experienced VACCINATION SITE MASS (Lumps the size of quarters in a 4 x4 inch patch, 3 inches below injection site) and PRURITUS (Light itching all over her body). On 24-Feb-2021, the patient experienced PERIPHERAL SWELLING (Arm was swollen to the elbow), ERYTHEMA (Arm was red) and SKIN MASS (Redness/swelling/lumpiness began to wrap around her arm to her armpit). In May 2021, the patient experienced MALAISE (Just didn't feel good). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. On 24-Feb-2021, PAIN IN EXTREMITY (Arm hurt), MIGRAINE (Migraine), VERTIGO (Vertigo), DIZZINESS (Dizziness), INFLUENZA LIKE ILLNESS (Flu like), ARTHRALGIA (Achy Muscle and joints), NAUSEA (Nausea) and MYALGIA (Achy Muscle and joints) had resolved. At the time of the report, VACCINATION SITE MASS (Lumps the size of quarters in a 4 x4 inch patch, 3 inches below injection site), PRURITUS (Light itching all over her body), MALAISE (Just didn't feel good), PERIPHERAL SWELLING (Arm was swollen to the elbow), ERYTHEMA (Arm was red) and SKIN MASS (Redness/swelling/lumpiness began to wrap around her arm to her armpit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.     This case was linked to MOD-2021-291127, MOD-2021-291781.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Vaccination site rash
Clinical narrative: broke out in a rash, rash came in her chest area one on each arm; it comes in 2s, it is going away gradually; chills; diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), VACCINATION SITE RASH (broke out in a rash, rash came in her chest area one on each arm; it comes in 2s, it is going away gradually) and CHILLS (chills) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041C21A and 003C21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy and Psoriasis. Concomitant products included METFORMIN, LISINOPRIL and ATORVASTATIN for an unknown indication.   On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In June 2021, the patient experienced DIARRHOEA (diarrhea) and CHILLS (chills). On an unknown date, the patient experienced VACCINATION SITE RASH (broke out in a rash, rash came in her chest area one on each arm; it comes in 2s, it is going away gradually). At the time of the report, DIARRHOEA (diarrhea) and CHILLS (chills) had resolved and VACCINATION SITE RASH (broke out in a rash, rash came in her chest area one on each arm; it comes in 2s, it is going away gradually) was resolving.            No treatment details were reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: metallic taste in mouth; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (metallic taste in mouth) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSGEUSIA (metallic taste in mouth). At the time of the report, DYSGEUSIA (metallic taste in mouth) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.  No treatment information was provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Second dose administered beyond 80 days after the first dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose administered beyond 80 days after the first dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Aug-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose administered beyond 80 days after the first dose). On 18-Aug-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose administered beyond 80 days after the first dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details were provided. No treatment information was mentioned.     Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: Unexpected Therapeutic Benefit; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (Unexpected Therapeutic Benefit) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     The patient's past medical history included Eye floaters (Patient stated that over a year she is suffering with folaters in her eyes specially In her left eye and have been crippling. Tow doctors told her nothing that can be done. she used eye drops for the same. she got relief from this after the 2nd dose administration.).   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Unexpected Therapeutic Benefit). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (Unexpected Therapeutic Benefit) had resolved.            Patient stated that - after the administration of 2nd dose of moderna she got relief from floaters and also she stopped using drops for that. unfortunately it didn't last, but improves her vision for several days, vaccine helped her tremendously. she wanted moderna people to look into eye drops or something better.
Sex: U
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: Side effect; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Side effect) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Side effect). At the time of the report, ADVERSE EVENT (Side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications was not provided by the reporter.  Treatment information was not provided.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Feeling abnormal, Muscle contracture, Muscle spasms, Myalgia
Clinical narrative: muscle spasms/ Cramps; muscles contracting every few minutes all day long/muscle squeezing; Diarrhea; feeling like her muscle disappeared and there was blubber left; Muscle pinching; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (muscle spasms/ Cramps), MUSCLE CONTRACTURE (muscles contracting every few minutes all day long/muscle squeezing), DIARRHOEA (Diarrhea), FEELING ABNORMAL (feeling like her muscle disappeared and there was blubber left) and MYALGIA (Muscle pinching) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included PARACETAMOL (TYLENOL) and IBUPROFEN for an unknown indication.    In June 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCLE SPASMS (muscle spasms/ Cramps), MUSCLE CONTRACTURE (muscles contracting every few minutes all day long/muscle squeezing), DIARRHOEA (Diarrhea), FEELING ABNORMAL (feeling like her muscle disappeared and there was blubber left) and MYALGIA (Muscle pinching). At the time of the report, MUSCLE SPASMS (muscle spasms/ Cramps), MUSCLE CONTRACTURE (muscles contracting every few minutes all day long/muscle squeezing), DIARRHOEA (Diarrhea), FEELING ABNORMAL (feeling like her muscle disappeared and there was blubber left) and MYALGIA (Muscle pinching) outcome was unknown.            Patient reported experiencing muscle pinching, muscles contracting every few minutes all day long, muscle squeezing, feeling like her muscle disappeared and there was blubber left. Patient reported that she felt better once she eats fruit.   Treatment information was not provided.   This case was linked to MOD-2021-290850.
Sex: U
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headahce; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headahce) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (headahce). At the time of the report, HEADACHE (headahce) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product was not provided by the reporter.  Treatment information was not provided.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: more than 36 days from first vaccination; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (more than 36 days from first vaccination) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (more than 36 days from first vaccination). At the time of the report, PRODUCT DOSE OMISSION ISSUE (more than 36 days from first vaccination) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter.  No treatment information was provided by the reporter.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, Cough, Dyspnoea, Product dose omission issue
Clinical narrative: Asthma; Not receiving second dose; Shortness of breath, couldn't breath with the mask on; Coughing; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath, couldn't breath with the mask on), COUGH (Coughing), ASTHMA (Asthma) and PRODUCT DOSE OMISSION ISSUE (Not receiving second dose) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided.  Concomitant products included POTASSIUM CHLORIDE and HYDROCHLOROTHIAZIDE for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2011, the patient experienced DYSPNOEA (Shortness of breath, couldn't breath with the mask on) and COUGH (Coughing). On an unknown date, the patient experienced ASTHMA (Asthma) and PRODUCT DOSE OMISSION ISSUE (Not receiving second dose). At the time of the report, DYSPNOEA (Shortness of breath, couldn't breath with the mask on), COUGH (Coughing) and ASTHMA (Asthma) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Not receiving second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included, using respiratory inhaler frequently, not other wise specified.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Asthenia, Cough, Decreased appetite
Clinical narrative: Not feeling well; Not feeling this way until receiving the shot; Weakness; Coughing; Does not have appetite; No taste (loss of taste); No smell (loss of smell); Stool is black/Black stool; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Not feeling well), FEELING ABNORMAL (Not feeling this way until receiving the shot), ASTHENIA (Weakness), COUGH (Coughing) and DECREASED APPETITE (Does not have appetite) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included APIXABAN (ELIQUIS) for an unknown indication.    On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (Not feeling well), FEELING ABNORMAL (Not feeling this way until receiving the shot), ASTHENIA (Weakness), COUGH (Coughing), DECREASED APPETITE (Does not have appetite), AGEUSIA (No taste (loss of taste)), ANOSMIA (No smell (loss of smell)) and FAECES DISCOLOURED (Stool is black/Black stool). At the time of the report, MALAISE (Not feeling well), FEELING ABNORMAL (Not feeling this way until receiving the shot), ASTHENIA (Weakness), COUGH (Coughing), DECREASED APPETITE (Does not have appetite), AGEUSIA (No taste (loss of taste)), ANOSMIA (No smell (loss of smell)) and FAECES DISCOLOURED (Stool is black/Black stool) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was on pacemaker prior to receiving the first dose of Moderna vaccine.  Second dose of the patient was scheduled on 04-Sep-2021.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Faeces discoloured, Feeling abnormal, Malaise
Clinical narrative: Not feeling well; Not feeling this way until receiving the shot; Weakness; Coughing; Does not have appetite; No taste (loss of taste); No smell (loss of smell); Stool is black/Black stool; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Not feeling well), FEELING ABNORMAL (Not feeling this way until receiving the shot), ASTHENIA (Weakness), COUGH (Coughing) and DECREASED APPETITE (Does not have appetite) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included APIXABAN (ELIQUIS) for an unknown indication.    On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (Not feeling well), FEELING ABNORMAL (Not feeling this way until receiving the shot), ASTHENIA (Weakness), COUGH (Coughing), DECREASED APPETITE (Does not have appetite), AGEUSIA (No taste (loss of taste)), ANOSMIA (No smell (loss of smell)) and FAECES DISCOLOURED (Stool is black/Black stool). At the time of the report, MALAISE (Not feeling well), FEELING ABNORMAL (Not feeling this way until receiving the shot), ASTHENIA (Weakness), COUGH (Coughing), DECREASED APPETITE (Does not have appetite), AGEUSIA (No taste (loss of taste)), ANOSMIA (No smell (loss of smell)) and FAECES DISCOLOURED (Stool is black/Black stool) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was on pacemaker prior to receiving the first dose of Moderna vaccine.  Second dose of the patient was scheduled on 04-Sep-2021.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discolouration
Clinical narrative: tinge in my injection site right arm after the first Moderna Covid-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (tinge in my injection site right arm after the first Moderna Covid-19 vaccine) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 010M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE DISCOLOURATION (tinge in my injection site right arm after the first Moderna Covid-19 vaccine). At the time of the report, VACCINATION SITE DISCOLOURATION (tinge in my injection site right arm after the first Moderna Covid-19 vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided by the reporter.  No treatment information was provided by the reporter.  The patient had no adverse reaction after her second Moderna COVID-19 vaccine.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Crohn's disease, Illness, Intentional dose omission, Pyrexia
Clinical narrative: wound up in a 10-week prednisone Crohn's flare/wound up in a bad Crohn's flare; got severely sick/it messed her up/it kicked her immunity; she did not get the second dose of the vaccine/Patient is receiveing the second dose of the vaccine tomorrow, which is more than 36 days after the first dose; high fever; This spontaneous case was reported by an other health care professional and describes the occurrence of CROHN'S DISEASE (wound up in a 10-week prednisone Crohn's flare, wound up in a bad Crohn's flare) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.   Concurrent medical conditions included Crohn's disease, Gut pain, Blood pressure management and Disorder thyroid. Concomitant products included LISINOPRIL for Blood pressure management, AZATHIOPRINE (IMURAN [AZATHIOPRINE]) for Crohn's disease, MESALAZINE (MESALAMINE) for Gut pain, ESTRADIOL for Hormone level abnormal, LEVOTHYROXINE for Thyroid disorder.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CROHN'S DISEASE (wound up in a 10-week prednisone Crohn's flare/wound up in a bad Crohn's flare) (seriousness criterion medically significant), ILLNESS (got severely sick/it messed her up/it kicked her immunity), PYREXIA (high fever) and INTENTIONAL DOSE OMISSION (she did not get the second dose of the vaccine/Patient is receiving the second dose of the vaccine tomorrow, which is more than 36 days after the first dose). The patient was treated with PREDNISONE ongoing since an unknown date for Crohn's aggravated, at an unspecified dose and frequency. At the time of the report, CROHN'S DISEASE (wound up in a 10-week prednisone Crohn's flare/wound up in a bad Crohn's flare) and ILLNESS (got severely sick/it messed her up/it kicked her immunity) outcome was unknown and PYREXIA (high fever) and INTENTIONAL DOSE OMISSION (she did not get the second dose of the vaccine/Patient is receiveing the second dose of the vaccine tomorrow, which is more than 36 days after the first dose) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient's high fever lasted 3 to 4 days following administration of mRNA-1273.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Second dose received more than 36 days after the first dose.; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose received more than 36 days after the first dose.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose received more than 36 days after the first dose.). On 15-Feb-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose received more than 36 days after the first dose.) had resolved.            Concomitant medication was not reported. Treatment information was not provided.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 2nd dose given 5 months after the 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose given 5 months after the 1st dose) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037A21A and 047C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jun-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose given 5 months after the 1st dose). On 21-Jun-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose given 5 months after the 1st dose) had resolved.            No concomitant medications provided. No treatment details reported.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, Extra dose administered
Clinical narrative: Immunocompromised patient received a 3rd dose of the Moderna vaccine from a vial that had been first punctured more than 12 hours ago; Immunocompromised patient received a 3rd dose of the Moderna vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Immunocompromised patient received a 3rd dose of the Moderna vaccine from a vial that had been first punctured more than 12 hours ago) and EXTRA DOSE ADMINISTERED (Immunocompromised patient received a 3rd dose of the Moderna vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised (Immunocompromised patient.).    On 18-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Immunocompromised patient received a 3rd dose of the Moderna vaccine from a vial that had been first punctured more than 12 hours ago) and EXTRA DOSE ADMINISTERED (Immunocompromised patient received a 3rd dose of the Moderna vaccine). On 18-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Immunocompromised patient received a 3rd dose of the Moderna vaccine from a vial that had been first punctured more than 12 hours ago) and EXTRA DOSE ADMINISTERED (Immunocompromised patient received a 3rd dose of the Moderna vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: She started with soreness in right arm.; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (She started with soreness in right arm.) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included SIMVASTATIN and LAMOTRIGINE (LAMICTAL) for an unknown indication.    On 17-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (She started with soreness in right arm.). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Myalgia, at an unspecified dose and frequency. At the time of the report, MYALGIA (She started with soreness in right arm.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medication also included Muscle spasm and acid reflux medicine.  Treatment medication also included rubbing alcohol.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Really high fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Really high fever) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced PYREXIA (Really high fever). At the time of the report, PYREXIA (Really high fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Feb-2021, Body temperature: high (High) High.         No concomitant medications were provided by the reporter.  No treatment information was provided by the reporter.   Reporter did not allow further contact
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Influenza like illness, Pyrexia
Clinical narrative: Flu like symptoms after first vaccine; Fever 102.5 F after first vaccine; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms after first vaccine) and PYREXIA (Fever 102.5 F after first vaccine) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jul-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms after first vaccine) and PYREXIA (Fever 102.5 F after first vaccine). The patient was treated with CAFFEINE, PARACETAMOL (EXCEDRIN [CAFFEINE;PARACETAMOL]) for Fever, at an unspecified dose and frequency. On 22-Jul-2021, INFLUENZA LIKE ILLNESS (Flu like symptoms after first vaccine) and PYREXIA (Fever 102.5 F after first vaccine) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Jul-2021, Body temperature: 102.5 (High) Body temperature was reported as 102.5 F.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were provided.   This case was linked to MOD-2021-290989 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Rheumatoid arthritis
Clinical narrative: diagnosed with Rheumatoid Arthritis; This spontaneous case was reported by a consumer and describes the occurrence of RHEUMATOID ARTHRITIS (diagnosed with Rheumatoid Arthritis) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RHEUMATOID ARTHRITIS (diagnosed with Rheumatoid Arthritis) (seriousness criterion medically significant). At the time of the report, RHEUMATOID ARTHRITIS (diagnosed with Rheumatoid Arthritis) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medical information were reported.  No treatment information was reported.  The patient reports that after she was diagnosed with Rheumatoid Arthritis that she went to a Reumatoid arthritis support group on social media. Several other patients on this  group report getting Rheumatoid Arthritis after receiving the Moderna Covid-19 vaccine.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chest pain, Product administered to patient of inappropriate age
Clinical narrative: Chest pain; Joint pain/ joints around his heart, rib cage, were being affected; 14-year-old; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pain), ARTHRALGIA (Joint pain/ joints around his heart, rib cage, were being affected) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (14-year-old) in a 14-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (Chest pain), ARTHRALGIA (Joint pain/ joints around his heart, rib cage, were being affected) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (14-year-old). At the time of the report, CHEST PAIN (Chest pain), ARTHRALGIA (Joint pain/ joints around his heart, rib cage, were being affected) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (14-year-old) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.  The patient stated that coworker took 14-year-old son to the ER because of having chest pain.  The patient did not know which vaccine patient received and ER doctor said they are finding that more people were complaining of joint pain, not just 24 hours after the shot. It's like long term now and said that the joints around heart, rib cage, were being affected.  The patient heard this from coworker and would like more information regarding joint pain.